DISTRICT OF COLUMBIA: Federal Bill Clears Way for D.C. to Fund Needle Exchange CDC Daily UpdateImportant note: Information in this article was accurate in 2007. The state of the art may have changed since the publication date.

Click here to return to CDC Daily Update main menu





DonateNow




DISTRICT OF COLUMBIA: Federal Bill Clears Way for D.C. to Fund Needle Exchange

Associated Press (12.27.07) - Friday, December 28, 2007
Stephen Manning


On Wednesday, President Bush signed an omnibus spending bill that also allows the District of Columbia to use its own money for needle exchange programs (NEPs). District officials welcomed the move reversing a nine-year ban, and said they will incorporate NEPs into city HIV prevention programs.

Since 1998, Congress has inserted language into spending packages that blocked the federal district from funding NEPs, which have had to rely on private financing. Washington has the worst AIDS rate of any US city, with about 128 cases per 100,000 residents, compared to a national 14 cases per 100,000 people, according to a D.C. report. About 20 percent of infections in the District are from intravenous drug users (IDUs) sharing needles, the city estimates.

Mayor Adrian M. Fenty said the city plans to devote about $1 million toward NEPs as part of its broader strategy to fight HIV/AIDS.

Eleanor Holmes Norton, the District's congressional delegate, said the shift in Congress from a Republican to Democratic majority made eliminating the local ban possible.

"This program will save lives," said Jim Graham, a D.C. Council member and former head of a city HIV/AIDS clinic.
071228
AD072693


Copyright © 2007 - Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Elton John AIDS Foundation, the National Library of Medicine, AIDS Walk of Orange County, and donations from users like you.

Always watch for outdated information. This article first appeared in 2007. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2007. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.

.